Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06861842 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06861842 · ClinicalTrials.gov record · last posted 2025-03-06

Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio® in Healthy Subjects

Name: Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio® in Healthy Subjects — clinical trial record (NCT06861842)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 4

SponsorCentro de Atencion e Investigacion Medica

Started2024-06-01

View on ClinicalTrials.gov ↗

Record status

This record was last updated March 6, 2025 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.

from the ClinicalTrials.gov record

A bioequivalence study of lithium carbonate will be developed in 24 healthy subjects, in fasting condition

Trial Details

NCT Number	NCT06861842
Lead Sponsor	Centro de Atencion e Investigacion Medica
Conditions	Healthy, Healthy Donors
Enrollment	24 participants
Start Date	2024-06-01
Primary Completion	2025-04-30 (estimated)
Study Completion	2025-04-30 (estimated)
Updated on ClinicalTrials.gov	2025-03-06